Sight Sciences, Inc. recently received Health Canada approval for the TRAB™360 Trabeculotomy System, which is indicated in Canada for the microcatheterization of Schlemm's canal and cutting of trabecular meshwork to lower intraocular pressure (IOP) in patients with primary open angle glaucoma (POAG).
The TRAB360 Trabeculotomy System is reportedly a fully-integrated, single-handed, single-use device that provides 360-degree access to Schlemm's canal via a single, sub-2mm, clear corneal incision. The device includes a custom-access cannula, a soft and flexible trabeculotome with an atraumatic tip, and a control wheel that moves the trabeculotome around Schlemm's canal.
Image courtesy Sight Sciences
Click here to read the full press release.
Source: Sight Sciences, Inc.